verified SJR 0,426 · Q3 • database Scopus / SJR & Web of Science indexed

United Kingdom · Wiley-Blackwell Publishing L...

workspace_premium Q3 — Hematology lock Subscription

Therapeutic Apheresis and Dialysis

Therapeutic Apheresis and Dialysis is a journal indexed in SJR in Hematology and Nephrology with an H index of 62. It has an SJR impact factor of 0,426 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,426.

ISSN: 1744-9979

Publisher: Wiley-Blackwell Publishing Ltd

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,426 Q3

H-index 62

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,426

H-index

Docs (year)

142

Docs 3y

477

Total refs

3745

Cites 3y

532

Citable 3y

369

Cites/Doc 2y

1.15

Ref/Doc

26.37

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cost-Effectiveness of Prosorba Column Therapy for Rheumatoid Arthritis: A Framework for Analysis

Vascular Access in Apheresis: Part II

Elevatedd-Dimer Level is a Risk Factor for Coronary Artery Lesions Accompanying Intravenous Immunoglobulin-Unresponsive Kawasaki Disease

Effects of Replacement Fluids on Plasma Viscosity Used for Therapeutic Plasma Exchange

Effective Maintenance Leukocytapheresis for Patients with Steroid Dependent or Resistant Ulcerative Colitis

Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant

DALI Low-Density Lipoprotein Apheresis in Homozygous and Heterozygous Familial Hypercholesterolemic Patients Using Low-Dose Citrate Anticoagulation

Current Topics on Therapeutic Apheresis Technologies: Had They Already Reached a Limit?

Current Topics on Low-Density Lipoprotein Apheresis

Current Topics on Immunoadsorption Therapy

Current Topics on Cytokine Removal Technologies

Current Topics on Cytapheresis Technologies

SHOW MORE ARTICLES

Current Status of Therapeutic Plasma Exchange in Korea

A Case of Thrombotic Thrombocytopenic Purpura Refractory to Plasma Exchange

Convective Dialysis Therapies, Current Status and Perspective

Congress President's Report: 4th World Congress of the International Society for Apheresis

Changes of Cytokines in Direct Endotoxin Adsorption Treatment on Postoperative Multiple Organ Failure

Apheresis Technology for Prevention and Regression of Atherosclerosis

Apheresis Technologies and Clinical Applications: The 2002 International Apheresis Registry

Apheresis Technologies and Clinical Applications: The 2000 International Apheresis Registry

Apheresis in Lupus Nephritis

Adsorption Technologies for Therapeutic Apheresis

Acute Changes in Plasma Levels of Hepatocyte Growth Factor During Low-Density Lipoprotein Apheresis

A Randomized Double-Blind Sham-Controlled Trial of the Prosorba Column for Treatment of Refractory Rheumatoid Arthritis

FAQs

Therapeutic Apheresis and Dialysis has an SJR of 0,426 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Therapeutic Apheresis and Dialysis is 29%.

Therapeutic Apheresis and Dialysis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Therapeutic Apheresis and Dialysis?

What is the APC / publication cost?

What is the acceptance rate?